Many people who get heart stents worry about taking blood thinners for the rest of their lives. For years, doctors have mostly prescribed aspirin as the standard long-term treatment. But some people cannot take aspirin because of stomach issues or other health problems. This research matters because it offers a possible alternative for those who need a safer option for daily heart protection. It gives hope to patients who have been stuck on aspirin for a decade or more.
Researchers followed over 5,400 patients who had already had their stents placed. These people had been taking both aspirin and clopidogrel together for six to eighteen months. After that time, they had no major heart problems. The team then asked them to choose between taking only aspirin or only clopidogrel for the rest of their lives. They tracked these patients for an average of ten and a half years to see who stayed healthy and who had trouble.
The results showed that the group taking clopidogrel alone did better than the group taking aspirin alone. About 25.4% of people on clopidogrel had a major heart event or died, compared to 28.5% of those on aspirin. This means clopidogrel helped prevent about three extra bad events for every hundred people treated. The study also found fewer heart attacks and strokes in the clopidogrel group. Even bleeding risks were slightly lower for those taking clopidogrel.
Safety was a major part of this long watch. The researchers specifically looked for serious bleeding events. They found that fewer people in the clopidogrel group had severe bleeding compared to the aspirin group. There were no reports of other serious side effects or reasons for patients to stop taking their medicine early. This suggests that clopidogrel is a well-tolerated option for long-term use.
It is important not to get too excited about this single study. It only included people who were already doing well after their stents. It did not test clopidogrel for people who had a heart attack right after getting a stent. Also, while the numbers look good, this is still one study, and doctors need more proof before changing standard rules. The study shows an association, meaning the medicine was linked to better results, but it does not prove it caused the improvement in every case.
For patients right now, this study suggests that clopidogrel could be a good choice for long-term heart protection if aspirin is not tolerated. It supports talking to your doctor about switching to clopidogrel if you have had a stent for years and are stable. Always discuss your specific health history with your care team before making any changes to your daily medicine.